Cargando…
Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment
Autores principales: | Sato, Hiromichi, Sasaki, Kazuki, Hara, Tomoaki, Kobayashi, Shogo, Doki, Yuichiro, Eguchi, Hidetoshi, Satoh, Taroh, Ishii, Hideshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634730/ https://www.ncbi.nlm.nih.gov/pubmed/36338771 http://dx.doi.org/10.3389/fonc.2022.1018333 |
Ejemplares similares
-
Drug Discovery and Development of miRNA-Based Nucleotide Drugs for Gastrointestinal Cancer
por: Sato, Hiromichi, et al.
Publicado: (2023) -
Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma
por: Sato, Hiromichi, et al.
Publicado: (2022) -
Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions
por: Sato, Hiromichi, et al.
Publicado: (2023) -
Pancreatic Cancer Research beyond DNA Mutations
por: Sato, Hiromichi, et al.
Publicado: (2022) -
Cancer metabolism challenges genomic instability and clonal evolution as therapeutic targets
por: Takeda, Yu, et al.
Publicado: (2022)